NEA is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With approximately $13 billion in committed capital, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 195 portfolio company IPOs and more than 320 acquisitions.
Maveron was founded in 1998 by Dan Levitan and Starbucks CEO Howard Schultz, and the firm has offices in Seattle and San Francisco. Maveron is a trendspotter in finding enduring brands with potential seeds of greatness and their expertise is in discovering passionate entrepreneurs who are ready to disrupt industries, displace incumbents, and establish market leading consumer businesses. Maveron investments include eBay, Shutterfly, August, Everlane, General Assembly, and Earnest.
Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on the Group’s strong capital base and long term commitment to the area, the company strives to become the ideal partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments and fund investments Nan Fung Life Sciences covers the full spectrum of the industry (including therapeutics, medical devices and diagnostics) across different development stages. Nan Fung Life Sciences is starting to build significant presence in the US and Greater China.
Other investors in Eargo include Charles and Helen Schwab, the Dolby Family Fund, Crosslink Capital, Birchmere Ventures, Montage Ventures, Red Sea Ventures, and Peterson Ventures. Our investors provide strategic support for our management and advisory teams, which include executives from disruptive and innovative companies such as Apple, Yahoo, Logitech, GoPro, and pioneering hearing health companies including HearingPlanet, Phonak and GN ReSound.